SOPHiA GENETICS S.A. is a Swiss healthcare technology company that provides a cloud-native software platform for data-driven medicine. The company's flagship product, the SOPHiA DDM platform, analyzes complex genomic, radiomic, and clinical data to help healthcare professionals diagnose and treat cancer and rare inherited disorders. Its platform leverages artificial intelligence and machine learning to pool data across a vast network of institutions, creating a collective intelligence that improves diagnostic accuracy and clinical decision-making. In addition to clinical applications, SOPHiA GENETICS partners with biopharmaceutical companies to support AI-powered drug discovery, clinical trial optimization, and companion diagnostic development. The company employs a software-as-a-service (SaaS) business model, driving adoption through a consumption-based approach across its global network of over 770 healthcare institutions.
